Rimas V. Lukas

Rimas V. Lukas

Hematology | Oncology
675 N Saint Clair St Ste 20-100
Chicago, IL 60611

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 205 publications

Spatial patterns of progression in reported glioblastoma cohorts after upfront chemoradiation and salvage therapy: a systematic review and meta-analysis.

Spatial patterns of progression in reported glioblastoma cohorts after upfront chemoradiation and salvage therapy: a systematic review and meta-analysis.

Journal: Journal of neuro-oncology
Published: June 01, 2026

Phase 1 evaluation of patients with newly diagnosed glioblastoma treated with radiation, nivolumab, and IDO1 enzyme inhibitor BMS-986205.

Phase 1 evaluation of patients with newly diagnosed glioblastoma treated with radiation, nivolumab, and IDO1 enzyme inhibitor BMS-986205.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 24, 2026

Epilepsy characteristics and outcomes in patients with pleomorphic xanthoastrocytomas.

Epilepsy characteristics and outcomes in patients with pleomorphic xanthoastrocytomas.

Journal: Journal of neuro-oncology
Published: March 23, 2026

Neurogenetic tumor syndromes: The current landscape of workup and treatment.

Neurogenetic tumor syndromes: The current landscape of workup and treatment.

Journal: Neuro-oncology practice
Published: March 09, 2026

Consideration of spatial companion biomarkers for targeted therapeutics in cancer: depatuxizumab mafodotin in glioblastoma.

Consideration of spatial companion biomarkers for targeted therapeutics in cancer: depatuxizumab mafodotin in glioblastoma.

Journal: JCI insight
Published: February 03, 2026

Survival and function in elderly patients with GBM: the role of surgical resection with contemporary multimodal therapy.

Survival and function in elderly patients with GBM: the role of surgical resection with contemporary multimodal therapy.

Journal: Journal of neuro-oncology
Published: January 12, 2026

A phase 2, open label, clinical trial of pre-surgical and adjuvant treatment of recurrent glioblastoma with tremelimumab and durvalumab alone and in combination.

A phase 2, open label, clinical trial of pre-surgical and adjuvant treatment of recurrent glioblastoma with tremelimumab and durvalumab alone and in combination.

Journal: Journal of neuro-oncology
Published: December 03, 2025

Surgical Treatment of Brain Tumor-Related Epilepsy: Current and Emerging Strategies.

Surgical Treatment of Brain Tumor-Related Epilepsy: Current and Emerging Strategies.

Journal: Cancers
Published: October 06, 2025

STING activation induces cytotoxic and immune responses in meningiomas via inflammatory cell death pathways.

STING activation induces cytotoxic and immune responses in meningiomas via inflammatory cell death pathways.

Journal: Nature communications
Published: October 03, 2025

Newly diagnosed glioblastoma IDHwt patients treated with radiation, nivolumab, and BMS-986205.

Newly diagnosed glioblastoma IDHwt patients treated with radiation, nivolumab, and BMS-986205.

Journal: Research square
Published: October 03, 2025

Reflecting on scientific growth and innovation as the Society for Neuro-Oncology turns 30.

Reflecting on scientific growth and innovation as the Society for Neuro-Oncology turns 30.

Journal: Neuro-oncology
Published: August 29, 2025

Reflecting on Scientific Growth and Innovation as the Society for Neuro-Oncology Turns 30.

Reflecting on Scientific Growth and Innovation as the Society for Neuro-Oncology Turns 30.

Journal: Neuro-oncology
Published: August 29, 2025
Showing 1-12 of 205

Last Updated: 09/26/2026